Short answer: Preimplantation genetic testing can support IVF outcomes in selected cases by helping the medical team review embryos before transfer, but it is not a guarantee of pregnancy and it is not needed for every patient. The value of PGT depends on age, embryo number, previous miscarriage, known genetic risk, sperm factors, and the reason for treatment.
Patients often ask about PGT because they want to reduce uncertainty. That is understandable, especially after failed IVF cycles or pregnancy loss. The safest way to decide is to separate what the test can show from what it cannot show. PGT can provide genetic information about embryos that reach a suitable stage for biopsy. It cannot make an embryo implant, correct egg quality, or remove every pregnancy risk.
What PGT means in IVF
PGT is performed during an IVF cycle after eggs are retrieved, fertilized, and embryos are cultured in the laboratory. When an embryo reaches the blastocyst stage, a small number of cells may be biopsied from the outer cell layer. The embryo is usually frozen while the laboratory analyzes the sample.
The result helps the doctor and embryology team decide which embryo may be most appropriate for transfer. This decision still has to be reviewed with morphology, development timing, patient age, uterine preparation, sperm history, and the couple's medical records.
PGT-A and PGT-M are different
PGT-A looks for chromosome number problems, also called aneuploidy. It may be discussed with older maternal age, repeated miscarriage, repeated implantation failure, or a history that suggests a high rate of abnormal embryos.
PGT-M is different. It is used when there is a known single-gene condition in the family and the couple needs a targeted genetic review. This requires careful preparation before the IVF cycle, because the laboratory needs the right information before embryos are created.
How PGT may improve decision-making
The main benefit is selection clarity. If several embryos are available, PGT may help avoid transferring an embryo with a chromosomal result that is unlikely to lead to an ongoing pregnancy. This can reduce the number of transfers needed in some cases and may lower the emotional burden of repeated negative tests.
PGT can also help patients plan frozen embryo transfer timing more realistically. Instead of judging embryos only by appearance, the team can combine morphology with genetic information. That does not make the result perfect, but it gives the consultation a stronger evidence base.
Important limits patients should know
PGT is useful only if embryos reach a stage where biopsy is possible. If very few embryos develop, the decision may become more complex. Some patients may benefit from transfer without testing, while others may still prefer genetic information before transfer. This is why a blanket answer is not helpful.
Testing also does not replace uterine evaluation, sperm assessment, embryo culture quality, or good transfer planning. A genetically suitable embryo can still fail to implant, and an abnormal result can be emotionally difficult when few embryos are available.
Legal and ethical boundaries in Turkey
Genetic testing should be discussed within the clinical and legal framework of treatment in Turkey. Medical indications, inherited disease risk, embryo viability, and patient safety should be kept separate from elective preferences. Patients should ask the clinic to explain what testing is allowed, what result would change the plan, and whether the indication fits their case.
Questions to ask before choosing PGT
- Is the recommendation based on my age, miscarriage history, family history, or previous IVF results?
- How many embryos are expected to reach blastocyst stage?
- Would testing change which embryo is transferred first?
- What happens if no embryo receives a transferable result?
- Is this PGT-A, PGT-M, or another genetic test?